Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1101 E Marshall St
Richmond, VA 23298
Education & Training
- University of Rochester Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2011 - 2012
- University of Rochester Medical CenterResidency, Neurology, 2007 - 2011
- University of Arizona College of MedicineClass of 2007
- University of ArizonaBS, Molecular and Cellular Biology and Psychology, 2002
Certifications & Licensure
- VA State Medical License 2018 - 2026
- NC State Medical License 2020 - 2022
- UT State Medical License 2013 - 2020
- NY State Medical License 2011 - 2014
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Arnold Gold Humanism in Medicine Award University of Rochester, 2010
- Medical Student Prize for Excellence in Neurology American Academy of Neurology, 2007
- Join now to see all
Clinical Trials
- Rasch-analysis of Clinical Severity in FSHD Start of enrollment: 2016 Mar 01
Publications & Presentations
PubMed
- 1 citationsParental diagnostic delay and developmental outcomes in congenital and childhood-onset myotonic dystrophy type 1.Federica Trucco, Emilio Albamonte, Marika Pane, Federica Ricci, Adele D'amico
Developmental Medicine and Child Neurology. 2025-03-01 - Strength and functional correlates of reachable workspace in facioscapulohumeral muscular dystrophy.Leo H Wang, Maya N Hatch, Michael P McDermott, William B Martens, Katy Eichinger
Neuromuscular Disorders. 2025-03-01 - Prospective observational study of FKRP-related limb-girdle muscular dystrophy R9: A GRASP consortium study.Lindsay N Alfano, Meredith K James, Kristine Grosfjeld Petersen, Karen Rudolf, John Vissing
Annals of Clinical and Translational Neurology. 2025-02-01
Journal Articles
- The Impact of Congenital and Childhood Myotonic Dystrophy on Quality of Life: A Qualitative Study of Associated SymptomsJohnson NE, Luebbe E, Eastwood E, Chin N, Moxley RT 3rd, Heatwole CR, J Child Neurol, 1/1/2013
- New insights about the incidence, multisystem manifestations, and care of patients with congenital myotonic dystrophyHilbert JE, Johnson NE, Moxley RT 3rd, J Pediatr, 1/1/2013
- Myotonia congenita in a patient who presented with diplopia and ptosis [Letter to the editor]Odrzywolski K, Johnson NE, Twydell PT, Muscle Nerve, 1/1/2013
- Join now to see all
Press Mentions
- AB-1003 Trial for LGMD Proceeds After Positive RecommendationMarch 11th, 2025
- AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosing of First Participant in Second CohortMarch 7th, 2025
- Avidity Biosciences Reports Second Quarter 2021 Financial Results and Recent HighlightsAugust 9th, 2021
- Join now to see all
Grant Support
- Identifying the RNA Splicing and Gene Expression Changes that Cause Congenital Myotonic Dystrophy (Renewal)VIRGINIA COMMONWEALTH UNIVERSITY2018–2029
- Trial Readiness and Endpoint Assessment in LGMDR1 (TREATing-LGMDR1)VIRGINIA COMMONWEALTH UNIVERSITY2023–2028
- Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type-1 (Renewal)VIRGINIA COMMONWEALTH UNIVERSITY2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: